Insider trading activity on Friday included major purchases at Optimum Communications, REGENXBIO and Pulse Biosciences, while directors at Life Time Group Holdings, Relay Therapeutics and Snowflake executed multi-million-dollar sales.
Optimum Communications disclosed that Director Neil S. Subin acquired 3,032,354 shares of Class A common stock between July 29 and August 25 through indirect holdings in Dark Mirage LP, where he serves as President and Manager of MILFAM LLC. The purchases totaled approximately $2.45 million at prices ranging from $0.7415 to $0.85 per share. The stock has gained 20% over the past week but remains down 56% year-over-year.
REGENXBIO Director Gregory Austin Ciongoli made two purchases late last week, acquiring 49,196 shares at a weighted average price of $9.1411 on August 26 and 53,407 shares at $9.356 on August 27, for a combined total of $949,381. The stock was trading near $9.37, down about 13% over the prior week.
Pulse Biosciences COO Liane Rae Teplitsky bought 1,036 shares at $48.235 on August 26 and 1,034 shares at $48.35 on August 28, spending $99,965. The company’s stock is near its 52-week high of $50.90 and has delivered a 206% return over the past year.
United States Antimony CEO Gary C. Evans purchased 20,000 shares at $4.92 each on August 28 for $98,400, bringing his direct holdings to 2,590,028 shares. The stock has fallen roughly 46% over the past six months and was trading at $4.85 with a market capitalization of $711 million.
Battalion Oil Director William D. Rogers acquired 70,000 shares at a weighted average price of $1.3024 on August 26, spending $91,168. The shares were purchased near a 52-week low of $1.00 and have declined 76% over six months.
On the sell side, Life Time Group Holdings saw three directors and entities dispose of shares totaling $126.1 million on August 26. Green LTF Holdings II LP sold 2,826,651 shares at $43.80 each, while John Kristofer Galashan and John G. Danhakl each disposed of 2,879,154 shares through multiple entities. The stock was trading at $43.51 with a market capitalization of $9.91 billion following a 56% gain over the past year and a 64% year-to-date increase.
Relay Therapeutics disclosed that SVF Pauling (Cayman) Ltd sold 6,000,000 shares at $19.40 each on August 25 for approximately $116.4 million. The company’s market capitalization stood at $4.26 billion after a 426% surge over the past year.
Snowflake Director Benoit Dageville sold 50,000 shares at $309.44 each for $15.47 million on August 26, executing the trade under a pre-arranged 10b5-1 plan adopted April 3, 2026. The stock reached $328, trading near its 52-week high of $341.95 following a 95% gain over six months.
